← Eichor
Condition: Chronic Spontaneous Urticaria Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Chronic Spontaneous Urticaria

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar
Phase N/A · 1 location(s) · Celltrion HealthCare France · NCT07425639Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU)
Phase 2 · 1 location(s) · Keymed Biosciences Co.Ltd · NCT07166211Analysis of the Role of IgE Proteoforms in Health and Disease
Phase N/A · 1 location(s) · KU Leuven · NCT07328178Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chron
Phase 2 · 17 location(s) · Novartis Pharmaceuticals · NCT06865651A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria Patients
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT07408219Remibrutinib in Real-world Clinical Practice - a US Sub-study
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT07358780Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-
Phase 2 · 30 location(s) · Yuhan Corporation · NCT07415551A Study to Describe the Real-world Effectiveness, Safety and Patterns of Use of Dupilumab in Patients With Chronic Spont
Phase N/A · 1 location(s) · Sanofi · NCT07316114Extending Omalizumab Treatment Intervals in Patients With Chronic Spontaneous Urticaria
Phase 4 · 1 location(s) · Simon Francis Thomsen · NCT05916937Remibrutinib in Real-world Clinical Practice
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT07358364A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity o
Phase 1/Phase 2 · 10 location(s) · Bambusa Therapeutics · NCT07717905A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneou
Phase 3 · 130 location(s) · Novartis Pharmaceuticals · NCT06868212Trial of JYB1904 in Chronic Spontaneous Urticaria.
Phase 2 · 1 location(s) · Jemincare · NCT06509334SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
Phase N/A · 8 location(s) · Leiden University Medical Center · NCT07021495Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous Urticaria
Phase 2/Phase 3 · 30 location(s) · Beijing InnoCare Pharma Tech Co., Ltd. · NCT07378527A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of
Phase 1 · 1 location(s) · Enanta Pharmaceuticals, Inc · NCT07540910A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
Phase 2 · 69 location(s) · Pfizer · NCT07219615Interleukin-2 for Refractory Chronic Spontaneous Urticaria
Phase 2/Phase 3 · 1 location(s) · Second Xiangya Hospital of Central South University · NCT06924762An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
Phase 2 · 3 location(s) · ARS Pharmaceuticals, Inc. · NCT06927999
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.